At this year’s Oncology Professional Care at Excel London, Oraldent is excited to highlight the Xerostom Mucosa Topical Gel, a premier product within the Xerostom range. This gel is especially beneficial for patients undergoing aggressive cancer treatments like chemotherapy and radiotherapy, which frequently leads to mouth inflammation and dry mouth due to significant decrease in saliva production and changes in saliva composition.

The Xerostom Mucosa Gel is specifically developed to address the oral health challenges faced by cancer patients, providing a comforting, protective film that promotes hydration and healing. It is enriched with natural antioxidants, moisturisers and lubricants that help maintain the health of the oral mucosa, by forming a protective film and is designed to help reduce inflammation, avoid irritation, stimulate salivary flow, soothe mouth sores and ulcers, alleviate discomfort during and after radiotherapy and chemotherapy treatments.

Clinically proven to offer effective relief and free from any harsh chemicals, this vegan-friendly gel provides a gentle yet effective approach to managing symptoms of dry mouth associated with cancer treatments.

Discover the benefits of Xerostom Mucosa Gel at Stand F40 during the Oncology Professional Care on May 21-22, 2024. For more details, contact Oraldent at 01480 862080, email info@oraldent.co.uk or visit oraldent.co.uk.